v3.26.1
Stockholders' Equity (Deficit) (Tables)
6 Months Ended
Jun. 30, 2026
Stockholders' Equity (Deficit)  
Schedule of stock-based compensation expense

For the Three Months Ended

For the Six Months Ended

  ​ ​ ​

June 30, 

  ​ ​ ​

June 30, 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Research and development

$

4,187

$

157,291

$

43,121

$

221,968

Selling, general and administrative

1,628,162

5,516,363

3,393,714

5,731,314

$

1,632,349

$

5,673,654

$

3,436,835

$

5,953,282

Schedule of the warrant activity and related information The following table presents information related to warrants as of June 30, 2026:

Warrants Outstanding

Warrants Exercisable

Weighted

Outstanding

Average

Exercisable

Exercise

  ​ ​ ​

Number of

  ​ ​ ​

Remaining Life

  ​ ​ ​

Number of

Price

Warrants

In Years

Warrants

$

3.2500

32,615,381

4.0

32,615,381

$

4.0000

 

350,000

 

4.0

 

350,000

$

5.2720

 

394,234

 

4.1

 

394,234

$

8.6080

 

302,045

 

3.6

 

302,045

$

197.5680

 

108,696

 

3.6

 

108,696

$

217.9200

 

49,280

 

3.5

 

49,280

$

380.8000

 

1,149

 

4.9

 

1,149

 

33,820,785

 

4.0

 

33,820,785

Summary of the restricted stock units activity

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Weighted

Average

Number of

Grant Date

  ​ ​ ​

RSUs

  ​ ​ ​

Price

RSUs non-vested January 1, 2026

 

1,545,000

$

6.63

Granted

 

355,077

 

3.26

Vested

 

(252,684)

 

5.33

RSUs non-vested June 30, 2026

 

1,647,393

$

6.18

Vested RSUs undelivered January 1, 2026

 

284,551

$

5.49

Vested during the period

252,684

5.33

Delivered- net of shares withheld for taxes

(259,029)

5.46

Shares withheld to satisfy employee tax obligations

(104,655)

5.01

Vested RSUs undelivered June 30, 2026

173,551

$

4.83